Treatment of Hypercholesterolaemia with Pcsk-9-Inhibitors in Denmark. Assessment of Real-Life Data; Extent and Efficacy After the First Years of Clinical Use

Autor: J. Clausen, Juliane Theilade, H Kanstrup, Jan Skov Jensen, Kristian Korsgaard Thomsen, Finn Lund Henriksen, Jakob Knold, J. Bech, M H Martinsen, K. M. Yafasov, L. J. Andersen, L. H. Kobbelgaard, Kenneth Egstrup, Merete Heitmann, S Mulverstedt, I. C. Klausen
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Zdroj: Mulverstedt, S, Klausen, I C, Martinsen, M H, Kanstrup, H, Thomsen, K K, Bech, J, Henriksen, F L, Knold, J, Andersen, L J, Kobbelgaard, L H, Theilade, J, Clausen, J, Yafasov, K M, Egstrup, K, Jensen, J S & Heitmann, M 2019, ' Treatment of Hypercholesterolaemia with Pcsk-9-Inhibitors in Denmark. Assessment of Real-Life Data; Extent and Efficacy After the First Years of Clinical Use ', Atherosclerosis, vol. 287, EAS19-0731, pp. E39-E40 . https://doi.org/10.1016/j.atherosclerosis.2019.06.114
Mulverstedt, S, Klausen, I C, Martinsen, M H, Kanstrup, H, Thomsen, K K, Bech, J, Henriksen, F L, Knold, J, Andersen, L J, Kobbelgaard, L H, Theilade, J, Clausen, J, Yafasov, K M, Egstrup, K, Jensen, J S & Heitmann, M 2019, ' Treatment of Hypercholesterolaemia With PCSK-9-Inhibitors in Denmark Assessment of Real-Life Data; Extent and Efficacy After the First Years of clinical Use ', Atherosclerosis, vol. 287, pp. E39-E40 . https://doi.org/10.1016/j.atherosclerosis.2019.06.114
DOI: 10.1016/j.atherosclerosis.2019.06.114
Databáze: OpenAIRE